Venlafaxine
Generic For Effexor XR
starting at $24.99

Venlafaxine is a serotonin and norepinephrine reuptake inhibitor (SNRI) used to treat depression. Treatment of depression can require trial of different SNRIs or SSRIs one at a time to find the best fit for you. Noticeable improvements in mood usually appear after 4 weeks of daily use with a recommended trial period of 4 to 12 weeks.

  • Used for the treatment of depression by restoring the balance of both serotonin and norepinephrine in the brain to improve mood
  • Initially dosed at 37.5 mg daily in the morning
  • May increase dose depending on response and tolerability
  • Improvement in physical symptoms within 1 to 2 weeks, and overall well-being after 4 weeks of daily use
(Must Click Below)
(Select After Clicking Dosage)
(Select After Clicking Dosage)

Venlafaxine

Web-form is not active.
For illustration purposes only. Product appearance may vary based on manufacturer availability.
  • Side Effects

    Side effects may include nausea, drowsiness, dry mouth, constipation, and loss of appetite.

  • Consumer Information Use and Disclaimer

    This information should not be used to decide whether or not to take this medicine or any other medicine. Only a healthcare provider has the knowledge and training to decide which medicines are right for you. TelyRx does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a limited summary of general information about the medicine’s uses from the patient education materials and is not intended to be comprehensive. This limited summary does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this medicine. This information is not intended to provide medical advice, diagnosis or treatment and does not replace information you may receive from your healthcare provider. For a more detailed summary of information about the risks and benefits of using this medicine, please review the entire patient education information you receive with the medication.